SEVERE COMBINED IMMUNODEFICIENCY CAUSED BY DEFECTS IN COMMON CYTOKINE RECEPTOR γc SIGNALING PATHWAYS

[1]  S. Müller,et al.  Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency. , 1999, The Journal of pediatrics.

[2]  J. Church,et al.  Severe Combined Immunodeficiency: Otolaryngological Presentation and Management , 1999, The Annals of otology, rhinology, and laryngology.

[3]  P. Appasamy.  Biological and clinical implications of interleukin-7 and lymphopoiesis. , 1999, Cytokines, cellular & molecular therapy.

[4]  A. Fischer.  Thirty years of bone marrow transplantation for severe combined immunodeficiency. , 1999, The New England journal of medicine.

[5]  J. Roberts,et al.  Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 1999, The New England journal of medicine.

[6]  H. Ochs,et al.  A novel mutant γc chain from a patient with typical phenotype of X‐linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL‐2 and IL‐4 receptor action , 1999, Clinical and experimental immunology.

[7]  J Wagner,et al.  B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome , 1999, Bone Marrow Transplantation.

[8]  K. Sugamura,et al.  Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency. , 1999, Blood.

[9]  K. Schwarz,et al.  Mutations in the gene for the common gamma chain (γc) in X-linked severe combined immunodeficiency , 1998, Human Genetics.

[10]  Steven F. Ziegler,et al.  Defective IL7R expression in T-B+NK + severe combined immunodeficiency , 1998, Nature Genetics.

[11]  T. Dassopoulos,et al.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.

[12]  Sandro Santagata,et al.  Partial V(D)J Recombination Activity Leads to Omenn Syndrome , 1998, Cell.

[13]  J. Tschopp,et al.  Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. , 1998, Immunity.

[14]  A. Fischer,et al.  Natural and engineered disorders of lymphocyte development. , 1998, Science.

[15]  J. D. Di Santo,et al.  In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development. , 1998, Current opinion in immunology.

[16]  Hirohisa Imai.  Cost analysis of treatments for severe combined immunodeficiency patients caused by adenosine deaminase deficiency: comparison of gene therapy and bone marrow transplantation. , 1998, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

[17]  C. Roifman,et al.  An interleukin-2 receptor gamma chain mutation with normal thymus morphology. , 1997, The Journal of clinical investigation.

[18]  A. Villa,et al.  Structural and functional basis for JAK3-deficient severe combined immunodeficiency. , 1997, Blood.

[19]  Werner Müller,et al.  On the role of the common cytokine receptor γ chain in B-cell vs. T-cell development , 1997, Research in Immunology.

[20]  J. Disanto,et al.  Cytokines: Shared receptors, distinct functions , 1997, Current Biology.

[21]  P. Clark,et al.  B-cell-negative severe combined immunodeficiency associated with a common γ chain mutation , 1997, Human Genetics.

[22]  H. Dadi,et al.  Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor , 1997 .

[23]  A. Fischer,et al.  Deregulated TCRαβ T cell population provokes extramedullary hematopoiesis in mice deficient in the common γ chain , 1997 .

[24]  J. Puck,et al.  Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. , 1997, Blood.

[25]  J. Johnston,et al.  Interleukin-4 Signaling in B Lymphocytes from Patients with X-linked Severe Combined Immunodeficiency* , 1997, The Journal of Biological Chemistry.

[26]  M. Ogawa,et al.  Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. , 1997, Immunity.

[27]  J. Puck,et al.  Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. , 1997, The Journal of pediatrics.

[28]  Rosen Fs.  Severe combined immunodeficiency: a pediatric emergency. , 1997, The Journal of pediatrics.

[29]  C. Croce,et al.  A potential role for interleukin-15 in the regulation of human natural killer cell survival. , 1997, The Journal of clinical investigation.

[30]  W. Leonard,et al.  The Common Cytokine Receptor γ Chain Plays an Essential Role in Regulating Lymphoid Homeostasis , 1997, The Journal of experimental medicine.

[31]  J. Puck,et al.  Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. , 1996, The New England journal of medicine.

[32]  U. Dirksen,et al.  Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. , 1996, The New England journal of medicine.

[33]  I. Puzanov,et al.  IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. , 1996, Journal of immunology.

[34]  U. Pannicke,et al.  RAG Mutations in Human B Cell-Negative SCID , 1996, Science.

[35]  A. Fischer,et al.  T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient , 1996 .

[36]  J. Miyazaki,et al.  Interleukin 7 receptor-deficient mice lack gammadelta T cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Sugamura,et al.  gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. , 1996, Blood.

[38]  J. Johnston,et al.  Retroviral-mediated gene correction for X-linked severe combined immunodeficiency. , 1996, Blood.

[39]  N. Taylor,et al.  Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene. , 1996, Blood.

[40]  M. Caligiuri,et al.  Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. , 1996, Blood.

[41]  M. Bogue,et al.  Mechanism of V(D)J recombination. , 1996, Cancer surveys.

[42]  K. Izuhara,et al.  Signal Transduction Pathway of Interleukin-4 and Interleukin-13 in Human B Cells Derived from X-linked Severe Combined Immunodeficiency Patients (*) , 1996, The Journal of Biological Chemistry.

[43]  J. D. Di Santo,et al.  Common cytokine receptor gamma chain (gamma c)-dependent cytokines: understanding in vivo functions by gene targeting. , 1995, Immunological reviews.

[44]  W. Leonard,et al.  Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development , 1995, Science.

[45]  J. Ihle.  Cytokine receptor signalling , 1995, Nature.

[46]  F. Alt,et al.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.

[47]  J. Puck,et al.  Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency. , 1995, American journal of human genetics.

[48]  T. Taniguchi.  Cytokine signaling through nonreceptor protein tyrosine kinases. , 1995, Science.

[49]  S. Burdach,et al.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.

[50]  E. Brooks,et al.  Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency. , 1995, The Journal of clinical investigation.

[51]  A. Fischer,et al.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Ware,et al.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.

[53]  F. Rieux-Laucat,et al.  Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[54]  W. Leonard,et al.  The defective gene in X-linked severe combined immunodeficiency encodes a shared interleukin receptor subunit: implications for cytokine pleiotropy and redundancy. , 1994, Current opinion in immunology.

[55]  J. Sleasman,et al.  Arrested rearrangement of TCR V beta genes in thymocytes from children with X-linked severe combined immunodeficiency disease. , 1994, Journal of immunology.

[56]  V. Fung,et al.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.

[57]  W. Leonard,et al.  The Molecular Basis of X‐Linked Severe Combined Immunodeficiency: The Role of the Interleukin‐2 Receptor γ Chain as a Common γ Chain, γc , 1994, Immunological reviews.

[58]  A. Fischer,et al.  Interleukin‐2 (IL‐2) receptor γ chain mutations in X‐linked severe combined immunodeficiency disease result in the loss of high‐affinity IL‐2 receptor binding , 1994, European journal of immunology.

[59]  A. Fischer,et al.  Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. , 1993, The Journal of pediatrics.

[60]  A. Fischer.  Primary T-cell immunodeficiencies. , 1993, Current opinion in immunology.

[61]  R. Sorensen,et al.  Disseminated bacillus Calmette-Guérin infections in patients with primary immunodeficiencies. , 1993, American journal of clinical pathology.

[62]  A. Monaco,et al.  Fine mapping of the human SCIDX1 locus at Xq12-13.1. , 1993, Human molecular genetics.

[63]  W. Leonard,et al.  Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.

[64]  Martin Bachmann,et al.  Disruption of the murine IL-4 gene blocks Th2 cytokine responses , 1993, Nature.

[65]  O. Parolini,et al.  Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency. , 1993, Journal of immunology.

[66]  N. Tanaka,et al.  Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.

[67]  A. Fischer,et al.  Genetic study of a new X-linked recessive immunodeficiency syndrome. , 1992, The Journal of clinical investigation.

[68]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[69]  A. Weiner,et al.  Genetic evidence for base pairing between U2 and U6 snRNA in mammalian mRNA splicing , 1991, Nature.

[70]  I. Horak,et al.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.

[71]  E. Brooks,et al.  A novel X-linked combined immunodeficiency disease. , 1990, The Journal of clinical investigation.

[72]  C. Griscelli,et al.  Human severe combined immunodeficiency disease: phenotypic and functional characteristics of peripheral B lymphocytes. , 1990, Journal of immunology.

[73]  N. Flomenberg,et al.  Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells , 1990, The Journal of experimental medicine.

[74]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.

[75]  J. Puck,et al.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[76]  A. Fischer,et al.  Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[77]  E. Lotzová,et al.  Immunoregulation in an Isolated 12-year-old Boy with Congenital Severe Combined Immunodeficiency , 1984, Pediatric Research.

[78]  C. Griscelli,et al.  Severe combined immunodeficiency disease: a pathological analysis of 26 cases. , 1983, Clinical immunology and immunopathology.

[79]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[80]  J. Renauld,et al.  Interleukin 9 and its receptor: an overview of structure and function. , 1998, International reviews of immunology.

[81]  W. Leonard,et al.  Jaks and STATs: biological implications. , 1998, Annual review of immunology.

[82]  J. Banchereau,et al.  Interleukin-4 and interleukin-13: their similarities and discrepancies. , 1998, International reviews of immunology.

[83]  A. Flake,et al.  In utero hematopoietic stem cell transplantation. A status report. , 1997, JAMA.

[84]  J. Puck,et al.  Mutation Analysis of IL 2 RG in Human X-Linked Severe Combined Immunodeficiency , 1997 .

[85]  C. Martínez-A,et al.  Lessons from immunological, biochemical, and molecular pathways of the activation mediated by IL-2 and IL-4. , 1996, Advances in immunology.

[86]  A. Fischer,et al.  T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient. , 1996, Blood.

[87]  N. Tanaka,et al.  The Common γ-Chain for Multiple Cytokine Receptors , 1995 .

[88]  F. Rosen,et al.  The primary immunodeficiencies. , 1995, The New England journal of medicine.

[89]  P. Gell,et al.  Clinical aspects of immunology , 1968 .